X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1450) 1450
humans (1263) 1263
hypercalcemia - chemically induced (1237) 1237
female (779) 779
male (733) 733
animals (476) 476
middle aged (440) 440
calcium - blood (365) 365
adult (340) 340
abridged index medicus (337) 337
hypercalcemia (332) 332
aged (322) 322
rats (258) 258
hypercalcemia - drug therapy (177) 177
vitamin d (154) 154
vitamin d - adverse effects (150) 150
calcium (146) 146
medicine, general & internal (141) 141
hypercalcemia - etiology (136) 136
calcium - metabolism (131) 131
parathyroid hormone - blood (130) 130
hypercalcemia - blood (124) 124
hypercalcemia - complications (124) 124
endocrinology & metabolism (117) 117
time factors (107) 107
hypercalcemia - diagnosis (94) 94
dose-response relationship, drug (93) 93
urology & nephrology (91) 91
hypocalcemia - chemically induced (90) 90
hypercalcemia - metabolism (88) 88
mice (86) 86
child (85) 85
phosphates - blood (83) 83
infant (81) 81
parathyroid hormone (80) 80
phosphorus - blood (76) 76
vitamin d - administration & dosage (76) 76
calcitriol - adverse effects (75) 75
calcium - urine (74) 74
aged, 80 and over (73) 73
adolescent (70) 70
hypercalcemia - physiopathology (70) 70
pregnancy (70) 70
treatment outcome (70) 70
oncology (68) 68
calcium carbonate - adverse effects (67) 67
diphosphonates - adverse effects (66) 66
diphosphonates - therapeutic use (66) 66
parathyroid-hormone (64) 64
diagnosis, differential (63) 63
therapy (61) 61
vitamin d - therapeutic use (61) 61
vitamin d - poisoning (60) 60
renal dialysis (59) 59
administration, oral (58) 58
child, preschool (57) 57
hyperparathyroidism (57) 57
hyperparathyroidism - chemically induced (57) 57
osteoporosis (56) 56
pediatrics (55) 55
pharmacology & pharmacy (54) 54
antacids - adverse effects (52) 52
bone density conservation agents - adverse effects (52) 52
breast neoplasms - drug therapy (52) 52
calcitriol - analogs & derivatives (52) 52
calcitriol - therapeutic use (52) 52
calcinosis - chemically induced (49) 49
dogs (49) 49
calcitriol (46) 46
cancer (46) 46
risk factors (46) 46
hypercalcemia - prevention & control (45) 45
thyroidectomy (45) 45
calcifediol (44) 44
care and treatment (44) 44
cholecalciferol - adverse effects (44) 44
hypercalcemia - therapy (44) 44
lithium - adverse effects (44) 44
metabolism (44) 44
acute kidney injury - chemically induced (43) 43
alfacalcidol (43) 43
bone and bones - metabolism (43) 43
calcium - adverse effects (43) 43
hypercalcemia - pathology (43) 43
hypoparathyroidism - drug therapy (43) 43
osteoporosis - drug therapy (43) 43
bipolar disorder - drug therapy (42) 42
calcitriol - administration & dosage (42) 42
health aspects (42) 42
hyperparathyroidism - complications (42) 42
drug administration schedule (41) 41
medicine & public health (41) 41
vitamin d - analogs & derivatives (41) 41
bone density conservation agents - therapeutic use (40) 40
vitamin d - blood (39) 39
parathyroid hormone - pharmacology (38) 38
neoplasms - complications (37) 37
bisphosphonates (36) 36
dietary supplements (36) 36
ergocalciferols - adverse effects (36) 36
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1354) 1354
French (89) 89
German (71) 71
Spanish (24) 24
Japanese (23) 23
Polish (15) 15
Russian (12) 12
Norwegian (9) 9
Danish (8) 8
Dutch (8) 8
Italian (8) 8
Hungarian (5) 5
Swedish (5) 5
Czech (3) 3
Romanian (3) 3
Bulgarian (2) 2
Finnish (2) 2
Chinese (1) 1
Croatian (1) 1
Hebrew (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Medicine, ISSN 1549-1277, 08/2016, Volume 13, Issue 8, pp. e1002058 - e1002058
Background There is limited, poorly characterized information about adverse events occurring during maintenance treatment of bipolar disorder. We aimed to... 
GLOMERULAR-FILTRATION-RATE | MEDICINE, GENERAL & INTERNAL | PRIMARY-CARE | MANAGEMENT | METAANALYSIS | PROPENSITY SCORE METHODS | BIAS | DATABASES | MODEL | CHRONIC KIDNEY-DISEASE | LITHIUM | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Renal Insufficiency - chemically induced | Antipsychotic Agents - therapeutic use | Hypertension - chemically induced | Adult | Female | Valproic Acid - therapeutic use | Thyroid Diseases - chemically induced | Valproic Acid - adverse effects | Chemical and Drug Induced Liver Injury - etiology | Quetiapine Fumarate - adverse effects | Hypercalcemia - chemically induced | Lithium Compounds - adverse effects | Bipolar Disorder - drug therapy | Quetiapine Fumarate - therapeutic use | Propensity Score | Lithium Compounds - therapeutic use | Benzodiazepines - adverse effects | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - chemically induced | Benzodiazepines - therapeutic use | Longitudinal Studies | Cohort Studies | Type 2 diabetes | Complications and side effects | Chronic kidney failure | Antidepressants | Primary health care | Analysis | Family medicine | Bipolar disorder | Dosage and administration | Management | Drug therapy | Hypertension | Substance abuse treatment | Thyroid diseases | Cardiovascular disease | Metabolism | Primary care | Patients | Studies | Confidence intervals | Collaboration | Physiology | Diabetes | Kidney diseases | Index Medicus
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 03/2007, Volume 146, Issue 5, pp. 326 - 339
Journal Article
Journal Article
Journal of Clinical Endocrinology and Metabolism, ISSN 0021-972X, 05/2017, Volume 102, Issue 5, pp. 1505 - 1510
Journal Article
JAMA, ISSN 0098-7484, 08/2016, Volume 316, Issue 7, pp. 722 - 733
Journal Article
JAMA, ISSN 0098-7484, 02/2012, Volume 307, Issue 7, pp. 674 - 684
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2011, Volume 365, Issue 5, pp. 410 - 421
Journal Article
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 01/2014, Volume 25, Issue 1, pp. 175 - 186
Journal Article
Clinical and Experimental Dermatology, ISSN 0307-6938, 12/2016, Volume 41, Issue 8, pp. 899 - 901
A 55‐year‐old man with severe plaque psoriasis presented with a 2‐week history of feeling generally unwell with lethargy and thirst. His symptoms had developed... 
CALCIPOTRIOL | DERMATOLOGY | Vitamins - adverse effects | Psoriasis - drug therapy | Humans | Middle Aged | Calcitriol - adverse effects | Male | Acute Kidney Injury - chemically induced | Hypercalcemia - chemically induced | Administration, Topical | Dermatologic Agents - adverse effects | Calcifediol | Prescription writing | Alfacalcidol | Psoriasis | Vitamin D | Kidneys | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2007, Volume 357, Issue 3, pp. 308 - 309
To the Editor: Vitamin D intoxication that is associated with the consumption of dietary supplements is reported rarely. 1 In 2004, the Food and Drug... 
MEDICINE, GENERAL & INTERNAL | Vitamin D - poisoning | Humans | Middle Aged | Female | Hypercalcemia - chemically induced | Drug and Narcotic Control | Dietary Supplements - poisoning
Journal Article